Compare LGVN & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGVN | UPXI |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6M | 125.8M |
| IPO Year | 2021 | 2021 |
| Metric | LGVN | UPXI |
|---|---|---|
| Price | $0.51 | $1.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.50 | $6.00 |
| AVG Volume (30 Days) | 426.5K | ★ 3.7M |
| Earning Date | 11-04-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.85 |
| Revenue | $1,437,000.00 | ★ $20,694,575.00 |
| Revenue This Year | N/A | $145.75 |
| Revenue Next Year | N/A | $12.88 |
| P/E Ratio | ★ N/A | $1.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.52 | $1.79 |
| 52 Week High | $2.24 | $22.57 |
| Indicator | LGVN | UPXI |
|---|---|---|
| Relative Strength Index (RSI) | 31.31 | 29.63 |
| Support Level | $0.52 | $1.79 |
| Resistance Level | $0.57 | $2.12 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 0.21 | 2.22 |
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.